Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus

INTRODUCTION: Sodium glucose co-transporter 2 inhibitors decrease hemoglobin A1c (HbA1c) and blood pressure (BP) and slightly increase low-density lipoprotein cholesterol (LDL-C) in patients with type 2 diabetes mellitus (T2DM). The effects of baseline BP and LDL-C on the safety and efficacy of cana...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Nobuya, Goda, Maki, Yokota, Shoko, Maruyama, Nobuko, Iijima, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662712/
https://www.ncbi.nlm.nih.gov/pubmed/26530268
http://dx.doi.org/10.1007/s12325-015-0255-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662712/
https://www.ncbi.nlm.nih.gov/pubmed/26530268
http://dx.doi.org/10.1007/s12325-015-0255-8

Ejemplares similares